E Deconinck, C Vanhee, P H J Keizers, P Guinot, A Mihailova, P V Syversen, G Li-Ship, S Young, A Blazewicz, M Poplawska, J Loasby Al-Sayed, L Stengelshøj Olsen, O El-Atma, R Leist, K H Jönsson, M Afxentiou, M Mendoza Barrios, I Dorronsoro Diaz, M Zemser, A Kozokin, A Hackl, M J Portela, N Beerbaum, M Bertrand
The General European Official Medicines Control Laboratory (OMCL) Network (GEON), co-ordinated by the European Directorate for the Quality of Medicines & HealthCare (EDQM), regularly organises market surveillance studies on specific categories of suspected illegal or illegally traded products. These studies are generally based on a combination of retrospective and prospective data collection over a defined period of time. This paper reports the results of the most recent study in this context with the focus on health products containing non-Anatomical Therapeutic Chemical-International Nonproprietary Name (ATC-INN) molecules...
January 16, 2021: Drug Testing and Analysis